Trademark: 85362627
Status Date
Friday, November 29, 2019
Registration Number
4322812
Registration Date
Tuesday, April 23, 2013
Filing Date
Monday, July 4, 2011
Published for Opposition
Tuesday, July 17, 2012
Cancellation Date
Friday, November 29, 2019
5 Antibodies, proteins, T cell proteins and peptides for medical use, monoclonal antibodies for clinical or medical use, pharmaceutical and biochemical substances and preparations, namely, small molecules, and CD8O antagonists for the treatment of cancer, rheumatoid arthritis and auto-immune diseases; in vivo immunotherapeutic, immunoprophylactic and immunodiagnostic agents, preparations and substances for clinical or medical use; vaccines; protein conjugates; diagnostic and analytical preparations for medical and veterinary use, namely, products to diagnose and analyze tissue damage caused by inflammation due to auto-immune diseases; enzymes and enzyme preparations for clinical or medical use and the treatment of cancer, rheumatoid arthritis and auto-immune diseases; chemical products for use in medical science, namely, T-cell receptors, small molecule and protein therapeutics; pre-filled vials containing pharmaceuticals and bioceuticals, namely, small molecules and protein therapeutics involving T-cell receptors for the treatment of cancer, rheumatoid arthritis and auto-immune diseases
10 Apparatus and instruments for diagnostic and therapeutic research, namely, instruments for measuring tissue damage or movement in limbs or organs; display apparatus, namely, multi-well plates and arrays for medical or clinical diagnosis and analysis; surgical and medical apparatus and instruments, namely, injectors and syringes
42 Biotechnology services, namely, the development of T-cell receptor pharmaceutical products and technologies for the treatment of cancer, rheumatoid arthritis, inflammatory and auto-immune diseases; scientific and medical research and development of new technology for others in the field of biotechnology and genomics, pharmaceutical drug development services, and pharmaceutical product development; genetic engineering services, licensing intellectual property, namely, trademarks and patents in the field of biotechnology
Nov 29, 2019
Cancelled Sec. 8 (6-Yr)
Apr 23, 2018
Courtesy Reminder - Sec. 8 (6-Yr) E-Mailed
Apr 23, 2013
Registered-Principal Register
Mar 18, 2013
1(B) Basis Deleted; Proceed To Registration
Mar 5, 2013
Notice Of Allowance Cancelled
Mar 11, 2013
Case Assigned To Intent To Use Paralegal
Mar 5, 2013
Teas Delete 1(B) Basis Received
Sep 11, 2012
Noa E-Mailed - Sou Required From Applicant
Jul 17, 2012
Official Gazette Publication Confirmation E-Mailed
Jul 17, 2012
Published For Opposition
Jun 27, 2012
Notification Of Notice Of Publication E-Mailed
Jun 14, 2012
Law Office Publication Review Completed
Jun 13, 2012
Approved For Pub - Principal Register
May 17, 2012
Teas/Email Correspondence Entered
May 17, 2012
Correspondence Received In Law Office
May 4, 2012
Assigned To Lie
May 3, 2012
Teas Response To Office Action Received
Nov 3, 2011
Notification Of Non-Final Action E-Mailed
Nov 3, 2011
Non-Final Action E-Mailed
Nov 3, 2011
Non-Final Action Written
Oct 20, 2011
Assigned To Examiner
Jul 11, 2011
New Application Office Supplied Data Entered In Tram
Jul 7, 2011
New Application Entered In Tram
Trademark Alertz updated from USPTO on 2030-01-24
